- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
has the opinion in correspondence with the opinion of the Board of Directors of the Company, and none of the Director had the different opinion or abstention. 8 บริษัท เจ. เอส. พ.ีพร็อพเพอร์ตี ้จ ำกดั
operating results of the third quarter of 2018, ended 30 September 2018 To Director and Manager The Stock Exchange of Thailand The Board of Director’s meeting No. 7/2018 of General Engineering Public Company
The Board of Director of the Company (excluding the directors who had a conflict of interest on the Transaction as mentioned below) has considered and viewed the Transaction is reasonable and is
capital 9. Opinion of the Company’s Board of Directors The Board of Director of the Company (excluding the directors who had a conflict of interest on the Transaction as mentioned below) has considered and
Dhanasuwiwath) Director Executives Office of the Company Tel. 0-2194-8562
the Board of Directors of the Company. The Audit Committee has the opinion in correspondence with the opinion of the Board of Directors of the Company, and none of the Director had the different opinion
with the opinion of the Board of Directors of the Company, and none of the Director had the different opinion or abstention. Yours Sincerely, Chavalit Taratikundech (Mr.Chavalit Taratikundech) Company
appropriate and beneficial to the Company as stated in clause 7 above. 10. Opinion of the Audit Committee and/or the Director of the Company which is different from the opinion of the Board of Directors in